Arnica for Health & Longevity - Quick Reference Sheet

Arnica for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

Arnica is sold in two forms sharing little but a name: strong skin gels and tinctures, and extreme dilutions by mouth containing essentially nothing of the plant. The clearest evidence for the strong form is painful finger joints and fading bruises. Documented harms are a skin allergy extending to related plants and serious poisoning when the full-strength herb is swallowed. (Full Review)

Protocol

Standard topical protocol
Gel, 50 g arnica tincture per 100 g
1:20 extract, applied twice daily to the affected joint for three to six weeks
Time of day
Morning and evening
For soreness after training: immediately post-exercise, then four-hourly while awake
Competing approach — homeopathic oral
6C to 30C pellets
Five pellets three times daily, from the evening before a procedure to 7–14 days after
Time to effect
Joint pain
Two to three weeks
Twice-daily application; same-day relief is not expected
Bruising after a procedure
Days 5 to 7
Visible differences emerge around this point
Muscle soreness after hard training
72 hours
Lower soreness at 72 hours only; no change in performance or muscle damage

Benefits

Contraindications
  • Arnica or daisy-family allergy (positive sesquiterpene lactone or Compositae patch test)
  • Pregnancy at any stage and breastfeeding (oral herbal and topical)
  • Broken, ulcerated, infected or eczematous skin at the site
  • Labile INR (outside 2.0–3.0 in the prior three months), oral herbal
  • Child-Pugh B or C liver disease or kidney disease stage 4–5, oral herbal
  • Children under 12 years, any oral herbal preparation
  • Whole herb internally as tea, tincture or capsule, any health status
  • Open wounds, ulcers, mucous membranes and near the eyes
Key Interactions
  • Vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon): Caution, herbal form
  • Direct oral anticoagulants and heparins (apixaban, rivaroxaban, enoxaparin): Caution, herbal form
  • Antiplatelet drugs (aspirin, clopidogrel, ticagrelor): Caution
  • Over-the-counter analgesics (ibuprofen, naproxen, aspirin, topical diclofenac): Monitor
  • Bleeding-tendency supplements (fish oil, ginkgo, garlic extract, high-dose vitamin E, nattokinase, curcumin): Caution
  • Daisy-family supplements (echinacea, chamomile, feverfew, milk thistle, calendula, dandelion): Caution

Risk & Side Effects

  • High: Allergic contact dermatitis and Asteraceae cross-sensitisation; systemic poisoning from swallowing the whole herb
  • Medium: Local skin irritation from topical preparations
  • Low: Added bleeding tendency with antithrombotic treatment; forgone benefit from more effective alternatives
  • Speculative: Harm in pregnancy and breastfeeding; adulterated or substituted plant material

Monitoring

Marker Target Why
Compositae and sesquiterpene lactone patch test Negative reading at both 48 and 72 hours Detects the delayed daisy-family allergy before repeated exposure establishes it
INR (international normalised ratio) 2.0–3.0 when anticoagulated; below 1.2 when not Detects added bleeding tendency with a vitamin K antagonist
Platelet count 200–350 × 10⁹/L Reserve against which the herb's platelet inhibition is judged
ALT (alanine aminotransferase) 10–26 U/L in women, 10–33 U/L in men Detects the liver injury reported after ingesting the whole herb
hs-CRP (high-sensitivity C-reactive protein) Below 1.0 mg/L Separates local joint disease from a systemic inflammatory driver a skin-limited agent cannot reach

Cadence: Site inspected daily for week 1; symptoms at 3 and 6 weeks; INR at baseline and 2 weeks; clotting and liver measures at 4 weeks then 6-monthly where the herbal form continues with anticoagulation

Qualitative Assessment

  • Joint pain on a 0–100 line and hand or knee function, weekly at the same time of day
  • Time from procedure to the bruise becoming invisible under normal indoor light
  • Muscle soreness at 24, 48 and 72 hours after a hard session, same scale each time
  • Itch, redness or scaling at the application site — the earliest sign of developing allergy
  • Sleep interruptions attributable to pain, counted over a typical week
  • Absence of any change by 6 weeks, marking the agent as ineffective for that person